Summary
In order to evaluate the effects and mechanisms of celecoxib in inhibiting proliferation and inducing apoptosis on human pancreatic carcinoma cells, the anti-proliferative effect was measured by using methabenzthiazuron (MTT) assay. Cell cycle and apoptosis were analyzed by using flow cytometry (FCM), and the PGE2 levels in the supernatant of cultured pancreatic carcinoma cells were quantitated by enzyme-linked immunoabsordent assay (ELISA). Our results showed that celecoxib suppressed the production of PGE2 and inhibited the growth of JF-305 cells, and the anti-proliferative effect of celecoxib could be abolished by addition of PGE2. FCM revealed that celecoxib could inhibit proliferation and induce apoptosis by G1-S cell cycle arrest. It was concluded that cyclooxygenase-2 specific inhibitor celecoxib could inhibit proliferation and induced apoptosis of human pancreatic carcinoma cells via suppression of PGE2 production in vitro.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wu G S, Wang J H, Liu Z Yet al. Expression of cyclooxygenase-1 and-2 in extra-hepatic cholangiocarcinoma. HBPD INT, 2002, 1: 429
Cheng J, Imanishi H, Iijima Het al. Expression of cyclooxygenase-2 and cytosolic phospholipase A(2) in the liver tissue of patients with chronic hepatitis and liver cirrhosis. Hepatol Res, 2002, 23:185
Yoshimi K, Singo T, Masahiko T,et al. Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Res, 2002, 62: 1567
Mei ZY, Shi Z, Wang X Het al. Synthesis of COX-2 inhibitor celecoxib. Zhongguo Yiyao Gongye Zazhi (Chinese), 2000, 31: 433
Leung W K, To K F, Ng Y P. Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer. Br J Cancer, 2001, 84: 335
Tsujii M, Dubois R N. Alteration in cellular adhesion and apoptosis in epithelial cells overexpression prostaglandin endoperoxide synthase-2. Cell, 1995, 83: 493
Giardiello F M, Offerhaus G J, Dubois R N. The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. J Euro Can, 1995, 31A: 1071
Jacoby R F, Cole C E, Tutsch Ket al. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Res, 2000, 60: 1864
Richter M, Weiss M, Weinberger Iet al. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors. Carcinogenesis, 2001, 22: 17
Charalambous D, Skinner S A, O'Brien P E. Sulindac inhibits colorectal tumor growth, but not prostaglandin synthesis in the rat. J Gastroenterol Hepatol, 1998, 13: 1195
Author information
Authors and Affiliations
Additional information
WU Gaosong, male, born in 1966, Assoicate Professor, M. D., Ph.D.
Rights and permissions
About this article
Cite this article
Gaosong, W., Jilin, Y., Fang, D. et al. Celecoxib inhibits proliferation and induces apoptosis via cyclooxygenase-2 pathway in human pancreatic carcinoma cells. Current Medical Science 25, 42–44 (2005). https://doi.org/10.1007/BF02831383
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02831383